Public Affairs Contacts
Visit our Public Affairs Contacts page to access HHS media information as well as press office contact information for ASPA and HHS operating divisions, staff divisions and regional offices.
Latest News Releases
On Wednesday, the Food and Drug Administration announced that, in Fiscal Year 2019, the agency approved a total of 1,171 generic drugs, an all-time record, following a record 971 approvals in Fiscal Year 2018 and a record 937 approvals in Fiscal Year 2017.
Today, the U.S. Department of Health and Human Services published a new Guide for Clinicians on the Appropriate Dosage Reduction or Discontinuation of Long-Term Opioid Analgesics. Individual patients, as well as the health of the public, benefit when opioids are prescribed only when the benefit of using opioids outweighs the risks. But once a patient is on opioids for a prolonged duration, any abrupt change in the patient’s regimen may put the patient at risk of harm, and should include a thorough, deliberative case review and discussion with the patient. The HHS Guide provides advice to clinicians who are contemplating or initiating a change in opioid dosage.
The Department of Health and Human Services (HHS) announced proposed changes to modernize and clarify the regulations that interpret the Physician Self-Referral Law (the “Stark Law”) and the Federal Anti-Kickback Statute.
Sign Up for News Release Updates
Enter your email:
Subscribe to RSS
Receive latest updates